Welcome to the April 2013 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, the implications on intellectual property protection on the recent ruling of the Indian Supreme Court on Novartis’ Glivec. Plus, AstraZeneca CEO’s plan to revitalize the company. And a ranking of the global pharmaceutical majors on access to medicines and other news from the pharmaceutical/biopharmaceutical companies and their suppliers relating to global health initiatives and sustainability.

APIs
Indian Supreme Court Rejects Patent for Glivec by Novartis
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Ruling has implications for intellectual property protection for innovator drugs in India.

Advertisement:

Trends in safe handling of potent compounds in pharmaceutical manufacturing processes
Live Webcast: Wednesday, May 15, 2013 at 11:00 AM EDT
Register Free at www.pharmtech.com/trends

Global Feature
AstraZeneca's CEO Pascal Soriot’s Plan to Revitalize the Company
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.

Outsourcing
Outsourcing of Non-traditional Protein Expression Systems Increases
Eric Langer, president of BioPlan Associates
A recent study shows growth in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

Advertisement:

A Pragmatic Application of QbD: Turning Theory into Tangible Success
Live Webcast: Thursday, May 2, 2013 at 11:00 am EDT
Register Free at http://www.pharmtech.com/pragmatic

GlaxoSmithKline Tops Industry Rankings for Access to Medicines
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.